Global Lung Cancer Liquid Biopsy Market 2020 by Company, Type and Application, Forecast to 2025

Report ID: 51393 | Publish Date: May, 2020 | Pages: 156 | Format : PDF

Market Overview

The global Lung Cancer Liquid Biopsy market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.

The Lung Cancer Liquid Biopsy market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

Market segmentation

Lung Cancer Liquid Biopsy market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for revenue by Type and Application. This analysis can help you expand your business by targeting qualified niche markets.

Breakdown by Type, Lung Cancer Liquid Biopsy market has been segmented into CTCs, CtDNA, Exosomes And RNA, Others, etc.

Breakdown by Application, Lung Cancer Liquid Biopsy has been segmented into Clinics, Hospitals, Physicians' Office Laboratories, etc.

Regions and Countries Level Analysis

Regional analysis is another highly comprehensive part of the research and analysis study of the global Lung Cancer Liquid Biopsy market presented in the report. This section sheds light on the sales growth of different regional and country-level Lung Cancer Liquid Biopsy markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Lung Cancer Liquid Biopsy market.

For China, this report analyses the China market by players, Type and Application, for the period 2015-2025.

Competitive Landscape and Lung Cancer Liquid Biopsy Market Share Analysis

Lung Cancer Liquid Biopsy competitive landscape provides details by vendors, including company overview, company total revenue, market potential, global presence, Lung Cancer Liquid Biopsy revenue generated, market share, headquarters, SWOT analysis, product launch. For the period 2015-2020, this study provides the Lung Cancer Liquid Biopsy revenue and market share for each player covered in this report.

The major players covered in Lung Cancer Liquid Biopsy are: Biocept, Bgi, Qiagen, Exosome Diagnostics, Bard1, F. Hoffmann-La Roche, Agena Bioscience, Accuragen, etc. Among other players domestic and global, Lung Cancer Liquid Biopsy market share data is available for global, North America, Europe, Asia, Middle East and Africa and South America separately. Our analysts understand competitive strengths and provide competitive analysis for each competitor separately.

Market segment by players, this report covers

Biocept

Bgi

Qiagen

Exosome Diagnostics

Bard1

F. Hoffmann-La Roche

Agena Bioscience

Accuragen

Market segment by regions, regional analysis covers

North America (United States, Canada and Mexico)

Europe (Germany, France, UK, Russia and Italy)

Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)

South America (Brazil, Argentina)

MENA (Saudi Arabia, UAE, Turkey and South Africa)

Market segment by Type, covers:

CTCs

CtDNA

Exosomes And RNA

Others

Market segment by Application, can be divided into

Clinics

Hospitals

Physicians' Office Laboratories


Frequently Asked Questions

The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.

Market is segmented on the basis:

  • By Type
  • By Application
  • By Region
  • By Country
  • By Manufacturer

The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.

The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.

Table of Contents

1 Market Overview

1.1 Product Overview and Scope of Lung Cancer Liquid Biopsy

1.2 Classification of Lung Cancer Liquid Biopsy by Type

1.2.1 Overview: Global Lung Cancer Liquid Biopsy Revenue by Type: 2015 Versus 2019 Versus 2025

1.2.2 Global Lung Cancer Liquid Biopsy Revenue Market Share by Type in 2019

1.2.3 CTCs

1.2.4 CtDNA

1.2.5 Exosomes And RNA

1.2.6 Others

1.3 Global Lung Cancer Liquid Biopsy Market by Application

1.3.1 Overview: Global Lung Cancer Liquid Biopsy Revenue by Application: 2015 Versus 2019 Versus 2025

1.3.2 Clinics

1.3.3 Hospitals

1.3.4 Physicians' Office Laboratories

1.4 Global Lung Cancer Liquid Biopsy Market Size and Forecast (2015-2025)

1.5 Global Lung Cancer Liquid Biopsy Market Size by Regions: 2015 VS 2019 VS 2025

1.6 Global Lung Cancer Liquid Biopsy Market Size by Regions (2015-2020)

1.7 Global Lung Cancer Liquid Biopsy Market Size and Forecast by Regions (2020-2025)

1.7.1 North America Lung Cancer Liquid Biopsy Status and Prospect (2015-2025)

1.7.2 Europe Lung Cancer Liquid Biopsy Status and Prospect (2015-2025)

1.7.3 Asia Lung Cancer Liquid Biopsy Status and Prospect (2015-2025)

1.7.4 South America Lung Cancer Liquid Biopsy Status and Prospect (2015-2025)

1.7.5 Middle East & Africa Lung Cancer Liquid Biopsy Status and Prospect (2015-2025)

2 Company Profiles

2.1 Biocept

2.1.1 Biocept Details

2.1.2 Biocept Major Business and Total Revenue (Financial Highlights) Analysis

2.1.3 Biocept SWOT Analysis

2.1.4 Biocept Product and Services

2.1.5 Biocept Lung Cancer Liquid Biopsy Revenue, Gross Margin and Market Share (2018-2019)

2.2 Bgi

2.2.1 Bgi Details

2.2.2 Bgi Major Business and Total Revenue (Financial Highlights) Analysis

2.2.3 Bgi SWOT Analysis

2.2.4 Bgi Product and Services

2.2.5 Bgi Lung Cancer Liquid Biopsy Revenue, Gross Margin and Market Share (2018-2019)

2.3 Qiagen

2.3.1 Qiagen Details

2.3.2 Qiagen Major Business and Total Revenue (Financial Highlights) Analysis

2.3.3 Qiagen SWOT Analysis

2.3.4 Qiagen Product and Services

2.3.5 Qiagen Lung Cancer Liquid Biopsy Revenue, Gross Margin and Market Share (2018-2019)

2.4 Exosome Diagnostics

2.4.1 Exosome Diagnostics Details

2.4.2 Exosome Diagnostics Major Business and Total Revenue (Financial Highlights) Analysis

2.4.3 Exosome Diagnostics SWOT Analysis

2.4.4 Exosome Diagnostics Product and Services

2.4.5 Exosome Diagnostics Lung Cancer Liquid Biopsy Revenue, Gross Margin and Market Share (2018-2019)

2.5 Bard1

2.5.1 Bard1 Details

2.5.2 Bard1 Major Business and Total Revenue (Financial Highlights) Analysis

2.5.3 Bard1 SWOT Analysis

2.5.4 Bard1 Product and Services

2.5.5 Bard1 Lung Cancer Liquid Biopsy Revenue, Gross Margin and Market Share (2018-2019)

2.6 F. Hoffmann-La Roche

2.6.1 F. Hoffmann-La Roche Details

2.6.2 F. Hoffmann-La Roche Major Business and Total Revenue (Financial Highlights) Analysis

2.6.3 F. Hoffmann-La Roche SWOT Analysis

2.6.4 F. Hoffmann-La Roche Product and Services

2.6.5 F. Hoffmann-La Roche Lung Cancer Liquid Biopsy Revenue, Gross Margin and Market Share (2018-2019)

2.7 Agena Bioscience

2.7.1 Agena Bioscience Details

2.7.2 Agena Bioscience Major Business and Total Revenue (Financial Highlights) Analysis

2.7.3 Agena Bioscience SWOT Analysis

2.7.4 Agena Bioscience Product and Services

2.7.5 Agena Bioscience Lung Cancer Liquid Biopsy Revenue, Gross Margin and Market Share (2018-2019)

2.8 Accuragen

2.8.1 Accuragen Details

2.8.2 Accuragen Major Business and Total Revenue (Financial Highlights) Analysis

2.8.3 Accuragen SWOT Analysis

2.8.4 Accuragen Product and Services

2.8.5 Accuragen Lung Cancer Liquid Biopsy Revenue, Gross Margin and Market Share (2018-2019)

3 Market Competition, by Players

3.1 Global Lung Cancer Liquid Biopsy Market Size by Players (2015-2020)

3.2 China Lung Cancer Liquid Biopsy Market Size by Players (2015-2020)

3.3 Market Concentration Rate

3.3.1 Top 5 Lung Cancer Liquid Biopsy Players Market Share

3.3.2 Top 10 Lung Cancer Liquid Biopsy Players Market Share

4 North America Market Size and Forecast by Countries

4.1 North America Lung Cancer Liquid Biopsy Market Size by Countries (2015-2020)

4.2 North America Lung Cancer Liquid Biopsy Market Size and Forecast by Countries (2015-2026)

4.3 United States Lung Cancer Liquid Biopsy Market Size and Forecast (2015-2025)

4.4 Canada Lung Cancer Liquid Biopsy Market Size and Forecast (2015-2025)

4.5 Mexico Lung Cancer Liquid Biopsy Market Size and Forecast (2015-2025)

5 Europe Market Size and Forecast by Countries

5.1 Europe Lung Cancer Liquid Biopsy Market Size by Countries (2015-2020)

5.2 Europe Lung Cancer Liquid Biopsy Market Size and Forecast by Countries (2015-2026)

5.3 Germany Lung Cancer Liquid Biopsy Market Size and Forecast (2015-2025)

5.4 France Lung Cancer Liquid Biopsy Market Size and Forecast (2015-2025)

5.5 UK Lung Cancer Liquid Biopsy Market Size and Forecast (2015-2025)

5.6 Russia Lung Cancer Liquid Biopsy Market Size and Forecast (2015-2025)

5.7 Italy Lung Cancer Liquid Biopsy Market Size and Forecast (2015-2025)

6 Asia-Pacific Market Size and Forecast by Countries

6.1 Asia-Pacific Lung Cancer Liquid Biopsy Market Size by Regions (2015-2020)

6.2 Asia-Pacific Lung Cancer Liquid Biopsy Market Size and Forecast by Regions (2015-2026)

6.3 China Lung Cancer Liquid Biopsy Market Size and Forecast (2015-2025)

6.4 Japan Lung Cancer Liquid Biopsy Market Size and Forecast (2015-2025)

6.5 Korea Lung Cancer Liquid Biopsy Market Size and Forecast (2015-2025)

6.6 India Lung Cancer Liquid Biopsy Market Size and Forecast (2015-2025)

6.7 Southeast Asia Lung Cancer Liquid Biopsy Market Size and Forecast (2015-2025)

7 South America Market Size and Forecast by Countries

7.1 South America Lung Cancer Liquid Biopsy Market Size by Countries (2015-2020)

7.2 South America Lung Cancer Liquid Biopsy Market Size and Forecast by Countries (2015-2026)

7.3 Brazil Lung Cancer Liquid Biopsy Market Size and Forecast (2015-2025)

7.4 Argentina Lung Cancer Liquid Biopsy Market Size and Forecast (2015-2025)

8 Middle East & Africa Market Size and Forecast by Countries

8.1 Middle East & Africa Lung Cancer Liquid Biopsy Revenue by Regions (2015-2020)

8.2 Middle East & Africa Lung Cancer Liquid Biopsy Market Size and Forecast by Countries (2015-2026)

8.3 Saudi Arabia Lung Cancer Liquid Biopsy Market Size and Forecast (2015-2025)

8.4 UAE Lung Cancer Liquid Biopsy Market Size and Forecast (2015-2025)

8.5 Egypt Lung Cancer Liquid Biopsy Market Size and Forecast (2015-2025)

8.6 South Africa Lung Cancer Liquid Biopsy Market Size and Forecast (2015-2025)

9 Market Size Segment by Type

9.1 Global Lung Cancer Liquid Biopsy Market Size and Forecast by Type (2015-2025)

9.1.1 Global Lung Cancer Liquid Biopsy Market Size by Type (2015-2020)

9.1.2 Global Lung Cancer Liquid Biopsy Market Size Forecast by Type (2020-2025)

9.2 China Lung Cancer Liquid Biopsy Market Size and Forecast by Type (2015-2025)

9.2.1 China Lung Cancer Liquid Biopsy Market Size by Type (2015-2020)

9.2.2 China Lung Cancer Liquid Biopsy Market Size Forecast by Type (2020-2025)

10 Market Size Segment by Application

10.1 Global Lung Cancer Liquid Biopsy Market Size and Forecast by Application (2015-2025)

10.1.1 Global Lung Cancer Liquid Biopsy Market Size by Application (2015-2020)

10.1.2 Global Lung Cancer Liquid Biopsy Market Size Forecast by Application (2020-2025)

10.2 China Lung Cancer Liquid Biopsy Market Size and Forecast by Application (2015-2025)

10.2.1 China Lung Cancer Liquid Biopsy Market Size by Application (2015-2020)

10.2.2 China Lung Cancer Liquid Biopsy Market Size Forecast by Application (2020-2025)

11 Research Findings and Conclusion

12 Appendix

12.1 Methodology

12.2 Data Source

12.3 Disclaimer

12.4 About US

List of Tables

Table 1. Global Lung Cancer Liquid Biopsy Revenue (USD Million) by Type: 2015 Versus 2019 Versus 2025

Table 2. Breakdown of Lung Cancer Liquid Biopsy by Company Type (Tier 1, Tier 2 and Tier 3)

Table 3. Global Lung Cancer Liquid Biopsy Revenue (USD Million) by Application: 2015 Versus 2019 Versus 2025

Table 4. Global Market Lung Cancer Liquid Biopsy Market Size (USD Million) Comparison by Regions (2020-2025)

Table 5. Global Lung Cancer Liquid Biopsy Revenue (USD Million) by Regions (2015-2020)

Table 6. Global Lung Cancer Liquid Biopsy Revenue Share by Regions (2015-2020)

Table 7. Global Lung Cancer Liquid Biopsy Revenue (USD Million) by Regions (2020-2025)

Table 8. Global Lung Cancer Liquid Biopsy Revenue Market Share by Regions (2020-2025)

Table 9. Biocept Corporate Information, Location and Competitors

Table 10. Biocept Major Business

Table 11. Biocept Lung Cancer Liquid Biopsy Total Revenue (USD Million) (2017-2018)

Table 12. Biocept SWOT Analysis

Table 13. Biocept Lung Cancer Liquid Biopsy Product and Solutions

Table 14. Biocept Lung Cancer Liquid Biopsy Revenue (USD Million), Gross Margin and Market Share (2018-2019)

Table 15. Bgi Corporate Information, Location and Competitors

Table 16. Bgi Major Business

Table 17. Bgi Lung Cancer Liquid Biopsy Total Revenue (USD Million) (2018-2019)

Table 18. Bgi SWOT Analysis

Table 19. Bgi Lung Cancer Liquid Biopsy Product and Solutions

Table 20. Bgi Lung Cancer Liquid Biopsy Revenue (USD Million), Gross Margin and Market Share (2018-2019)

Table 21. Qiagen Corporate Information, Location and Competitors

Table 22. Qiagen Major Business

Table 23. Qiagen Lung Cancer Liquid Biopsy Total Revenue (USD Million) (2017-2018)

Table 24. Qiagen SWOT Analysis

Table 25. Qiagen Lung Cancer Liquid Biopsy Product and Solutions

Table 26. Qiagen Lung Cancer Liquid Biopsy Revenue (USD Million), Gross Margin and Market Share (2018-2019)

Table 27. Exosome Diagnostics Corporate Information, Location and Competitors

Table 28. Exosome Diagnostics Major Business

Table 29. Exosome Diagnostics Lung Cancer Liquid Biopsy Total Revenue (USD Million) (2017-2018)

Table 30. Exosome Diagnostics SWOT Analysis

Table 31. Exosome Diagnostics Lung Cancer Liquid Biopsy Product and Solutions

Table 32. Exosome Diagnostics Lung Cancer Liquid Biopsy Revenue (USD Million), Gross Margin and Market Share (2018-2019)

Table 33. Bard1 Corporate Information, Location and Competitors

Table 34. Bard1 Major Business

Table 35. Bard1 Lung Cancer Liquid Biopsy Total Revenue (USD Million) (2017-2018)

Table 36. Bard1 SWOT Analysis

Table 37. Bard1 Lung Cancer Liquid Biopsy Product and Solutions

Table 38. Bard1 Lung Cancer Liquid Biopsy Revenue (USD Million), Gross Margin and Market Share (2018-2019)

Table 39. F. Hoffmann-La Roche Corporate Information, Location and Competitors

Table 40. F. Hoffmann-La Roche Major Business

Table 41. F. Hoffmann-La Roche Lung Cancer Liquid Biopsy Total Revenue (USD Million) (2017-2018)

Table 42. F. Hoffmann-La Roche SWOT Analysis

Table 43. F. Hoffmann-La Roche Lung Cancer Liquid Biopsy Product and Solutions

Table 44. F. Hoffmann-La Roche Lung Cancer Liquid Biopsy Revenue (USD Million), Gross Margin and Market Share (2018-2019)

Table 45. Agena Bioscience Corporate Information, Location and Competitors

Table 46. Agena Bioscience Major Business

Table 47. Agena Bioscience Lung Cancer Liquid Biopsy Total Revenue (USD Million) (2017-2018)

Table 48. Agena Bioscience SWOT Analysis

Table 49. Agena Bioscience Lung Cancer Liquid Biopsy Product and Solutions

Table 50. Agena Bioscience Lung Cancer Liquid Biopsy Revenue (USD Million), Gross Margin and Market Share (2018-2019)

Table 51. Accuragen Corporate Information, Location and Competitors

Table 52. Accuragen Major Business

Table 53. Accuragen Lung Cancer Liquid Biopsy Total Revenue (USD Million) (2017-2018)

Table 54. Accuragen SWOT Analysis

Table 55. Accuragen Lung Cancer Liquid Biopsy Product and Solutions

Table 56. Accuragen Lung Cancer Liquid Biopsy Revenue (USD Million), Gross Margin and Market Share (2018-2019)

Table 57. Global Lung Cancer Liquid Biopsy Revenue (USD Million) by Players (2015-2020)

Table 58. Global Lung Cancer Liquid Biopsy Revenue Share by Players (2015-2020)

Table 59. Key Players Lung Cancer Liquid Biopsy Revenue (USD Million) in China (2015-2020)

Table 60. Key Players Lung Cancer Liquid Biopsy Revenue Share in China (2015-2020)

Table 61. North America Lung Cancer Liquid Biopsy Revenue (USD Million) by Countries (2015-2020)

Table 62. North America Lung Cancer Liquid Biopsy Revenue Market Share by Countries (2015-2020)

Table 63. North America Lung Cancer Liquid Biopsy Revenue (USD Million) by Countries (2020-2026)

Table 64. North America Lung Cancer Liquid Biopsy Revenue Market Share by Countries (2020-2026)

Table 65. Europe Lung Cancer Liquid Biopsy Revenue (USD Million) by Countries (2015-2020)

Table 66. Europe Lung Cancer Liquid Biopsy Revenue Market Share by Countries (2015-2020)

Table 67. Europe Lung Cancer Liquid Biopsy Revenue (USD Million) by Countries (2020-2026)

Table 68. Europe Lung Cancer Liquid Biopsy Revenue Market Share by Countries (2020-2026)

Table 69. Asia-Pacific Lung Cancer Liquid Biopsy Revenue (USD Million) by Countries (2015-2020)

Table 70. Asia-Pacific Lung Cancer Liquid Biopsy Revenue Market Share by Countries (2015-2020)

Table 71. Asia-Pacific Lung Cancer Liquid Biopsy Revenue (USD Million) by Countries (2020-2026)

Table 72. Asia-Pacific Lung Cancer Liquid Biopsy Revenue Market Share by Countries (2020-2026)

Table 73. South America Lung Cancer Liquid Biopsy Revenue (USD Million) by Countries (2015-2020)

Table 74. South America Lung Cancer Liquid Biopsy Revenue Market Share by Countries (2015-2020)

Table 75. South America Lung Cancer Liquid Biopsy Revenue (USD Million) by Countries (2020-2026)

Table 76. South America Lung Cancer Liquid Biopsy Revenue Market Share by Countries (2020-2026)

Table 77. Middle East & Africa Lung Cancer Liquid Biopsy Revenue (USD Million) by Countries (2015-2020)

Table 78. Middle East & Africa Lung Cancer Liquid Biopsy Revenue Market Share by Countries (2015-2020)

Table 79. Middle East & Africa Lung Cancer Liquid Biopsy Revenue (USD Million) by Countries (2020-2026)

Table 80. Middle East & Africa Lung Cancer Liquid Biopsy Revenue Market Share by Countries (2020-2026)

Table 81. Global Lung Cancer Liquid Biopsy Revenue (USD Million) by Type (2015-2020)

Table 82. Global Lung Cancer Liquid Biopsy Revenue Share by Type (2015-2020)

Table 83. Global Lung Cancer Liquid Biopsy Revenue Forecast by Type (2020-2025)

Table 84. Global Lung Cancer Liquid Biopsy Market Share Forecast by Type (2020-2025)

Table 85. China Lung Cancer Liquid Biopsy Revenue (USD Million) by Type (2015-2020)

Table 86. China Lung Cancer Liquid Biopsy Revenue Share by Type (2015-2020)

Table 87. China Lung Cancer Liquid Biopsy Revenue Forecast by Type (2020-2025)

Table 88. China Lung Cancer Liquid Biopsy Market Share Forecast by Type (2020-2025)

Table 89. Global Lung Cancer Liquid Biopsy Revenue (USD Million) by Application (2015-2020)

Table 90. Global Lung Cancer Liquid Biopsy Revenue Share by Application (2015-2020)

Table 91. Global Lung Cancer Liquid Biopsy Revenue Forecast by Application (2020-2025)

Table 92. Global Lung Cancer Liquid Biopsy Market Share Forecast by Application (2020-2025)

Table 93. China Lung Cancer Liquid Biopsy Revenue (USD Million) by Application (2015-2020)

Table 94. China Lung Cancer Liquid Biopsy Revenue Share by Application (2015-2020)

Table 95. China Lung Cancer Liquid Biopsy Revenue Forecast by Application (2020-2025)

Table 96. China Lung Cancer Liquid Biopsy Market Share Forecast by Application (2020-2025)

List of Figures

Figure 1. Lung Cancer Liquid Biopsy Picture

Figure 2. Global Lung Cancer Liquid Biopsy Market Share by Company Type (Tier 1, Tier 2 and Tier 3)

Figure 3. Global Lung Cancer Liquid Biopsy Revenue Market Share by Type in 2019

Figure 4. CTCs Picture

Figure 5. CtDNA Picture

Figure 6. Exosomes And RNA Picture

Figure 7. Others Picture

Figure 8. Lung Cancer Liquid Biopsy Revenue Market Share by Application in 2019

Figure 9. Clinics Picture

Figure 10. Hospitals Picture

Figure 11. Physicians' Office Laboratories Picture

Figure 12. Global Lung Cancer Liquid Biopsy Revenue and Growth Rate (2015-2025) (USD Million)

Figure 13. Global Lung Cancer Liquid Biopsy Market Size Share by Regions (2015-2025)

Figure 14. Global Lung Cancer Liquid Biopsy Market Size Share by Regions in 2019

Figure 15. Global Lung Cancer Liquid Biopsy Revenue Market Share by Regions (2020-2025)

Figure 16. North America Lung Cancer Liquid Biopsy Revenue (USD Million) and Growth Rate (2015-2025)

Figure 17. Europe Lung Cancer Liquid Biopsy Revenue (USD Million) and Growth Rate (2015-2025)

Figure 18. Asia-Pacific Lung Cancer Liquid Biopsy Revenue (USD Million) and Growth Rate (2015-2025)

Figure 19. South America Lung Cancer Liquid Biopsy Revenue (USD Million) and Growth Rate (2015-2025)

Figure 20. Middle East & Africa Lung Cancer Liquid Biopsy Revenue (USD Million) and Growth Rate (2015-2025)

Figure 21. Global Lung Cancer Liquid Biopsy Revenue Share by Players in 2019

Figure 22. Global Top 5 Players Lung Cancer Liquid Biopsy Revenue Market Share in 2019

Figure 23. Top 10 Players Lung Cancer Liquid Biopsy Revenue Market Share in Global Market in 2019

Figure 24. Global Lung Cancer Liquid Biopsy Market Size (USD Million) by Type (2015-2025)

Figure 25. Global Lung Cancer Liquid Biopsy Market Size Share by Application (2015-2025)

Figure 26. North America Lung Cancer Liquid Biopsy Market Size Share by Countries (2015-2025)

Figure 27. North America Lung Cancer Liquid Biopsy Market Size Share by Countries in 2019

Figure 28. United States Lung Cancer Liquid Biopsy Market Size (USD Million) and Forecast (2015-2025)

Figure 29. Canada Lung Cancer Liquid Biopsy Market Size (USD Million) and Forecast (2015-2025)

Figure 30. Mexico Lung Cancer Liquid Biopsy Market Size (USD Million) and Forecast (2015-2025)

Figure 31. Europe Lung Cancer Liquid Biopsy Market Size Share by Countries (2015-2025)

Figure 32. Europe Lung Cancer Liquid Biopsy Market Size Share by Countries in 2019

Figure 33. Germany Lung Cancer Liquid Biopsy Market Size (USD Million) and Forecast (2015-2025)

Figure 34. France Lung Cancer Liquid Biopsy Market Size (USD Million) and Forecast (2015-2025)

Figure 35. Russia Lung Cancer Liquid Biopsy Market Size (USD Million) and Forecast (2015-2025)

Figure 36. Italy Lung Cancer Liquid Biopsy Market Size (USD Million) and Forecast (2015-2025)

Figure 37. Spain Lung Cancer Liquid Biopsy Market Size (USD Million) and Forecast (2015-2025)

Figure 38. UK Lung Cancer Liquid Biopsy Market Size (USD Million) and Forecast (2015-2025)

Figure 39. Asia Lung Cancer Liquid Biopsy Market Size Share by Countries (2015-2025)

Figure 40. Asia Lung Cancer Liquid Biopsy Market Size Share by Countries in 2019

Figure 41. China Lung Cancer Liquid Biopsy Market Size (USD Million) and Forecast (2015-2025)

Figure 42. Japan Lung Cancer Liquid Biopsy Market Size (USD Million) and Forecast (2015-2025)

Figure 43. Korea Lung Cancer Liquid Biopsy Market Size (USD Million) and Forecast (2015-2025)

Figure 44. India Lung Cancer Liquid Biopsy Market Size (USD Million) and Forecast (2015-2025)

Figure 45. Southeast Asia Lung Cancer Liquid Biopsy Market Size (USD Million) and Forecast (2015-2025)

Figure 46. South America Lung Cancer Liquid Biopsy Market Size Share by Countries (2015-2025)

Figure 47. South America Lung Cancer Liquid Biopsy Market Size Share by Countries in 2019

Figure 48. Brazil Lung Cancer Liquid Biopsy Market Size (USD Million) and Forecast (2015-2025)

Figure 49. Argentina Lung Cancer Liquid Biopsy Market Size (USD Million) and Forecast (2015-2025)

Figure 50. Middle East & Africa Lung Cancer Liquid Biopsy Market Size Share by Countries (2015-2025)

Figure 51. Middle East & Africa Lung Cancer Liquid Biopsy Market Size Share by Countries in 2019

Figure 52. Saudi Arabia Lung Cancer Liquid Biopsy Market Size (USD Million) and Forecast (2015-2025)

Figure 53. UAE Lung Cancer Liquid Biopsy Market Size (USD Million) and Forecast (2015-2025)

Figure 54. Egypt Lung Cancer Liquid Biopsy Market Size (USD Million) and Forecast (2015-2025)

Figure 55. South Africa Lung Cancer Liquid Biopsy Market Size (USD Million) and Forecast (2015-2025)

Figure 56. Global Lung Cancer Liquid Biopsy Revenue Share by Type (2015-2020)

Figure 57. China Lung Cancer Liquid Biopsy Revenue Share by Type (2015-2020)

Figure 58. Global Lung Cancer Liquid Biopsy Revenue Share by Application (2015-2020)

Figure 59. China Lung Cancer Liquid Biopsy Revenue Share by Application (2015-2020)

Our Clients